Novo Nordisk has asked the FDA to dam production of compounded copies of copyright, arguing that it’s too challenging to do safely. It’s the latest escalation within a brewing war concerning pharmaceutical companies and compounders.Now, as lawmakers are closing in on illegal THC cartridges, the industry is receding into the shadows of the web,